Novapio Plus (Metformin Hydrochloride, Pioglitazone)

Metformin lowers hepatic glucose output and enhances peripheral insulin sensitivity by activating AMP‑activated protein kinase. Pioglitazone activates PPARγ receptors, altering gene transcription to increase insulin sensitivity in adipose tissue, muscle and liver, together providing complementary glucose‑lowering effects.

The appropriate dose of Novapio Plus is determined by the prescribing healthcare professional based on the individual’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of Novapio Plus during pregnancy and lactation has not been established. It is generally avoided unless the potential benefit justifies the possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To request Novapio Plus, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with separate metformin or pioglitazone tablets, Novapio Plus offers the convenience of a single combination pill and synergistic mechanisms that may improve adherence and glycemic control. Unlike sulfonylureas, it carries a lower intrinsic risk of hypoglycemia but requires monitoring for fluid retention and rare metabolic complications.

Novapio Plus should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Novapio Plus is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablet should be swallowed whole with a full glass of water and not crushed or chewed unless otherwise directed by a healthcare professional.

Patients should be alert for signs of lactic acidosis (e.g., unexplained muscle pain, rapid breathing, abdominal discomfort), new or worsening heart failure symptoms such as shortness of breath or swelling, and any unusual urinary symptoms that could indicate bladder concerns. Prompt medical evaluation is essential if these occur.

Novapio Plus is contraindicated in individuals with severe renal impairment, active liver disease, established heart failure, or a known hypersensitivity to metformin, pioglitazone, or any excipients. It should also be avoided in pregnant women unless clearly indicated by a physician.